AOBiome Targets Atopic Dermatitis Niche With Bacteria-Based Drug

Illustration of bacteria on colorful background, model of bacteria, microbes, microorganisms,
AOBiome announced Phase IIb data for its bacteria-based atopic dermatitis treatment, B244 • Source: Shutterstock

More from Dermatological

More from Therapy Areas